Michael Thomas Schweizer, Jayeta Chakrabarti, Sujata Narayanan, Stella Lin. "Mevrometostat (PF-06821497) in combination with enzalutamide for androgen receptor pathway inhibitor (ARPI)-naïve patients with metastatic castration-resistant prostate cancer (mCRPC): The phase 3, randomized MEVPRO-2 trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.tps287